Editas Medicine (EDIT) Net Margin (QoQ) (2015 - 2025)

Editas Medicine (EDIT) Net Margin (QoQ) (2015 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Editas Medicine 263.01 Mn 116.36 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 111,929.00
Jun 30, 2025 24,059.00
Mar 31, 2025 -154,387.00
Dec 31, 2024 10.17 Mn
Sep 30, 2024 -8.87 Mn
Jun 30, 2024 -738,094.00
Mar 31, 2024 -576,068.00
Dec 31, 2023 245,217.00
Sep 30, 2023 1.51 Mn
Jun 30, 2023 -1.47 Mn
Mar 31, 2023 -199,718.00
Dec 31, 2022 378.51 Mn
Sep 30, 2022 -376.85 Mn
Jun 30, 2022 4.17 Mn
Mar 31, 2022 -5.89 Mn
Dec 31, 2021 81,883.00
Sep 30, 2021 3.34 Mn
Jun 30, 2021 -3.29 Mn
Mar 31, 2021 -99,288.00
Dec 31, 2020 -55,977.00